US OptionsDetailed Quotes
VIR250117C15000
- 0.40
- +0.28+233.33%
15min DelayClose Jan 8 16:00 ET
1.15High0.25Low
0.25Open0.12Pre Close4.33K Volume366 Open Interest15.00Strike Price294.73KTurnover151.28%IV23.40%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type0.2466Delta0.1105Gamma33.28Leverage Ratio-0.0548Theta0.0006Rho8.21Eff Leverage0.0060Vega
Vir Biotechnology Stock Discussion
Sign in to post a comment
2
3
$Vir Biotechnology (VIR.US)$ bought in too high.. have to hold it.. potential stock for future.
1
1
$Vir Biotechnology (VIR.US)$
Congratulations to trader who have bought it on premarket for day trade profit.
Market is going downtrend for the incoming fed announcement. Lock on profit today as tomorrow market will be closed.
Today good opportunity to swing trade $ $Sana Biotechnology (SANA.US)$ $Absci Corp (ABSI.US)$
Pick the right momentum stock to trade for profit.
Follow me, follow momentum
Congratulations to trader who have bought it on premarket for day trade profit.
Market is going downtrend for the incoming fed announcement. Lock on profit today as tomorrow market will be closed.
Today good opportunity to swing trade $ $Sana Biotechnology (SANA.US)$ $Absci Corp (ABSI.US)$
Pick the right momentum stock to trade for profit.
Follow me, follow momentum
$Palantir (PLTR.US)$ nice cash grab. keep on holdin guys lol. $Vir Biotechnology (VIR.US)$ to the moon see u at 20
5
2
1
$Vir Biotechnology (VIR.US)$ Benzinga· 1 min ago
Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer
Vir Biotechnology Inc - Vir-5818 Shows 50% Tumor Shrinkage in Her2 Cancers at ≥400 ΜG/Kg
Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer
Vir Biotechnology Inc - Vir-5818 Shows 50% Tumor Shrinkage in Her2 Cancers at ≥400 ΜG/Kg
2
$Vir Biotechnology (VIR.US)$ $Eli Lilly and Co (LLY.US)$ Reuters· 2 mins ago
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
No comment yet
DDDDDDDDDDD : $Color Star Technology (ADD.US)$ and $Snow Lake Resources (LITM.US)$ lets go
Trytosaveabit OP DDDDDDDDDDD : Indeed! SS’s are Makin on those 2 today along with about 75% of the rest of the market! Hehehe
Jenna Ragan : wow!